Last updated on February 2019

Harvoni in Patients With Chronic Hepatitis C Virus (HCV) Infection in Korea


Brief description of study

The primary objective of this post-marketing surveillance study is to collect and assess data related to the safety and effectiveness of Harvoni (ledipasvir/sofosbuvir (LDV/SOF)) treatment regimen, per the approved Korea prescribing information for Harvoni, in routine clinical practice in Korea and to report the results to the Ministry of Food and Drug Safety (MFDS). Patients will be treated as part of routine practice at Korean healthcare centers by accredited physicians.

Clinical Study Identifier: NCT02951364

Contact Investigators or Research Sites near you

Start Over

Gilead Study Team

Soonchunhyang University Cheonan Hospital
Cheonan, Korea, Republic of
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.